TransMedics Group, Inc. TMDX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $7.32M-93.1% | $105.38M+333% | $24.32M-30.3% | $34.91M+35.9% | $25.68M+275% | ||
| $11.86M+58.9% | $7.47M+9.0% | $6.85M+1.8% | $6.73M+9.7% | $6.14M+8.0% | ||
| $9.95M+5.9% | $9.4M+2.8% | $9.14M-2.5% | $9.37M+4.6% | $8.96M-16.8% | ||
| $1.07M+105% | -$20.89M0.0% | -$20.89M0.0% | -$20.89M0.0% | -$20.89M— | ||
| —— | —— | —— | —— | -$80K-1,782% | ||
| $6.52M— | —— | -$24.15M— | —— | $44.13M+463% | ||
| $3.9M-40.3% | $6.53M-5.4% | $6.9M+286% | -$3.71M-85.4% | -$2M— | ||
| $1.13M+155% | -$2.06M-184% | $2.46M+306% | -$1.19M-252% | $781K+125% | ||
| -$3.11M-145% | $6.97M-47.0% | $13.14M+489% | $2.23M+148% | -$4.64M-300% | ||
| $155K+1,092% | $13K+117% | $6K— | —— | —— | ||
| $40K— | —— | $1.74M+432% | -$522K-258% | $330K+177% | ||
| -$805K-3.6% | -$777K-5.0% | -$740K-3.6% | -$714K-7.5% | -$664K-3.9% | ||
| $24.53M-28.9% | $34.51M-50.4% | $69.57M-24.1% | $91.61M+3,309% | -$2.86M-115% | ||
| $36.66M+136% | $15.51M+103% | $7.62M-16.0% | $9.08M-66.4% | $27.04M+98.7% | ||
| -$36.66M-136% | -$15.51M-103% | -$7.62M+16.0% | -$9.08M+66.4% | -$27.04M-98.7% | ||
| —— | —— | —— | —— | —— | ||
| $2.21M-28.6% | $3.1M+70.6% | $1.82M-74.4% | $7.09M+307% | $1.74M+46.9% | ||
| $138K+300% | $34.5K0.0% | $34.5K0.0% | $34.5K0.0% | $34.5K— | ||
| $3.76M+21.4% | $3.1M-14.9% | $3.64M-48.6% | $7.09M+134% | $3.03M+155% | ||
| -$327K-448% | $94K+944% | $9K-98.9% | $809K+126% | $358K+152% | ||
| -$8.69M-139% | $22.19M-66.2% | $65.6M-27.5% | $90.43M+441% | -$26.51M— | ||
| —— | $2.68M0.0% | $2.68M0.0% | $2.68M0.0% | $2.68M-5.3% | ||
| -$486K-445% | $141K+1,663% | $8K-99.1% | $900K+57.1% | $573K+161% | ||
| —— | —— | —— | —— | -$80K-1,782% | ||
| -$3.11M-145% | $6.97M-47.0% | $13.14M+489% | $2.23M+148% | -$4.64M-300% | ||
| -$805K-3.6% | -$777K-5.0% | -$740K-3.6% | -$714K-7.5% | -$664K-3.9% | ||
| -$1.96M— | —— | $5.9M— | —— | -$1.93M-1,084% | ||
| $4.59M— | —— | —— | —— | $787K— | ||
| $610K— | —— | —— | —— | $474K— | ||
| $1.69M— | —— | $1.96M— | —— | $1.29M— | ||
| $1.1M— | $0-100% | $548K+427% | $104K-90.8% | $1.14M+0.4% | ||
| —— | —— | —— | —— | —— | ||
| -$805K-3.6% | -$777K-5.0% | -$740K-3.6% | -$714K-7.5% | -$664K-3.9% | ||
| $2.83M+30.9% | $2.16M+70.8% | $1.27M+29.7% | $976K-23.5% | $1.28M+4.9% | ||
| $3.99M— | —— | —— | —— | —— | ||
| $340.04M— | —— | —— | —— | —— | ||
| $313K— | —— | $471K— | —— | —— | ||
| -$12.12M-164% | $19M-69.3% | $61.95M-24.9% | $82.53M+376% | -$29.89M— | ||
| -$12.12M-164% | $19M-69.3% | $61.95M-24.9% | $82.53M+376% | -$29.89M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does TransMedics Group, Inc. generate?
- TransMedics Group, Inc. (TMDX) generated $220.2M in operating cash flow over the trailing twelve months.
- What is TransMedics Group, Inc.'s free cash flow?
- After $68.9M of capital expenditures, TransMedics Group, Inc.'s free cash flow was $151.4M over the trailing twelve months, up 199.3% year over year.
- Where does TransMedics Group, Inc.'s cash flow data come from?
- Every line is extracted from TransMedics Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
